Activity of penciclovir in antiviral assays against herpes simplex virus

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 2, 1996, Pages 303-313

  Bacon, Teresa H ^a   Howard, Barbara A ^a   Spender, Lindsay C ^a,b   Boyd, Malcolm R ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; FAMCICLOVIR; PENCICLOVIR; VIRUS DNA;

ARTICLE; ASSAY; CYTOTOXICITY TEST; DNA SYNTHESIS INHIBITION; DRUG ACTIVITY; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; ORAL DRUG ADMINISTRATION; VIRUS INFECTION; VIRUS REPLICATION;

ACYCLOVIR; ANTIVIRAL AGENTS; CELL LINE; EVALUATION STUDIES; HERPESVIRUS 1, HUMAN; HERPESVIRUS 2, HUMAN; MICROBIAL SENSITIVITY TESTS; VIRUS REPLICATION;

EID: 0029916474     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.2.303     Document Type: Article

References (28)

1. Bacon, T. H., Howard, B. A., Gilbart, J., Page, J., Standring-Cox, R. & Boyd, M. R. (1993). Inhibition of varicella-zoster virus by penciclovir - in vitro studies, Antiviral Research 20, Suppl. 1, 109.
2. Bacon, T. H. & Schinazi, R. F. (1993). An overview of the further evaluation of penciclovir against herpes simplex virus and varicella-zoster virus in cell culture highlighting contrasts with acyclovir. Antiviral Chemistry and Chemotherapy 4, Suppl. 1, 25-36.
3. Boyd, M. R., Bacon, T. H. & Sutton, D. (1988). Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine (BRL 39123) in animals. Antimicrobial Agents and Chemotherapy 32, 358-63.
4. Boyd, M. R., Bacon, T. H., Sutton, D. & Cole, M. (1987). Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine (BRL 39123) in cell culture. Antimicrobial Agents and Chemotherapy 31, 1238-242.
5. Boyd, M. R., Safrin, S. & Kern, E. R. (1993). Penciclovir: a review of its spectrum of activity, selectivity, and cross-resistance pattern. Antiviral Chemistry and Chemotherapy 4, Suppl. 1, 3-11.
6. Collins, P. & Bauer, D. J. (1977). Relative potencies of anti-herpes compounds. Annals of the New York Academy of Science 284, 49-59.
7. Darby, G. (1993). The acyclovir legacy: its contribution to antiviral drug discovery. Journal of Medical Virology Suppl. 1, 134-8.
8. De Clercq, E. (1982). Comparative efficacy of antiherpes drugs in different cell lines. Antimicrobial Agents and Chemotherapy 21, 661-3.
9. de Miranda, P. & Blum, R. M. (1983). Pharmacokinetics of acyclovir after intravenous and oral administration. Journal of Antimicrobial Chemotherapy 12, Suppl. B, 29-37.
10. Earnshaw, D. L., Bacon, T. H., Darlison, S. J., Edmonds, K., Perkins, R. M. & Vere Hodge, R. A. (1992). Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus. Antimicrobial Agents and Chemotherapy 36, 2747-57.
11. Furman, P. A., St Clair, M. H., Fyfe, J. A., Rideout, J. L., Keller, P. M. & Elion, G. B. (1979). Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxvmethyl)guanine and its triphosphate. Journal of Virology 32, 72-7.
12. Gadler, H., Larsson, A. & Sølver, E. (1984). Nucleic acid hybridization, a method to determine effects of antiviral compounds on herpes simplex virus type 1 DNA synthesis. Antiviral Research 4, 63-70.
13. Harmenberg, J., Wahren, B. & Öberg, B. (1980). Influence of cells and virus multiplicity on the inhibition of herpesviruses with acycloguanosine. Intervirology 14, 239-44.
14. Harmenberg, J., Wahren, B., Sundqvist, V.-A. & Levén, B. (1985). Multiplicity dependence and sensitivity of herpes simplex virus isolates to antiviral compounds. Journal of Antimicrobial Chemotherapy 15, 567-73.
15. Hill, T. J., Field, H. J. & Blyth, W. A. (1975). Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease. Journal of General Virology 28, 341-53.
16. Littler, E. (1994). Safety and efficacy issues of herpesvirus drugs. Antiviral Chemistry and Chemotherapy 5, Suppl. 1, 11-6.
17. Pue, M. A., Pratt, S. K., Fairless, A. J., Fowles, S., Laroche, J., Georgiou, P. et al. (1994). Linear pharmacokinetics of penciclovir following administration of single oral doses of famciclovir 125, 250, 500 and 750 mg to healthy volunteers. Journal of Antimicrobial Chemotherapy 33, 119-27.
18. Rabalais, G. P., Levin, M. J. & Berkowitz, F. E. (1987). Rapid herpes simplex virus susceptibility testing using an enzyme-linked immunosorbent assay performed in situ on fixed virus-infected monolayers. Antimicrobial Agents and Chemotherapy 31, 946-8.
19. Roizman, B. & Sears, A. E. (1993). Herpes simplex viruses and their replication. In The Human Herpesviruses (Roizman, B., Whitley, R. J. & Lopez, C., Eds), pp. 11-68. Raven Press, New York.
20. Standring-Cox, R., Bacon, T. H., Howard, B. A., Gilbart, J. & Boyd, M. R. (1994). Prolonged activity of penciclovir in cell cultures against varicella-zoster virus. Antiviral Research 23, Suppl. 1, 96.
21. Sutton, D. & Kern, E. R. (1993). Activity of famciclovir and penciclovir in HSV-infected animals: a review. Antiviral Chemistry and Chemotherapy 4, Suppl. 1, 37-46.
22. Swierkosz, E. M., Scholl, D. R., Brown, J. L., Jollick, J. D. & Gleaves, C. A. (1987). Improved DNA hybridization method for detection of acyclovir-resistant herpes simplex virus. Antimicrobial Agents and Chemotherapy 31, 1465-9.
23. Vere Hodge, R. A. & Cheng, Y.-C. (1993). The mode of action of penciclovir. Antiviral Chemistry and Chemotherapy 4, Suppl. 1, 13-24.
24. Vere Hodge, R. A. & Perkins, R. M. (1989). Mode of action of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cells. Antimicrobial Agents and Chemotherapy 33, 223-9.
25. Vere Hodge, R. A., Sutton, D., Boyd, M. R., Harnden, M. R. & Jarvest, R. L. (1989). Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9(4-hydroxy-3-hydroxymethylbut-1-yl)guanine: penciclovir]. Antimicrobial Agents and Chemotherapy 33, 1765-73.
26. Wahren, B., Harmenberg, J., Sundqvist, V.-A., Levén, B. & Sköldenberg, B. (1983). A novel method For determining the sensitivity of herpes simplex virus to antiviral compounds. Journal of Virological Methods 6, 141-9.
27. Weinberg, A., Bate, B. J., Masters, H. B., Schneider, S. A., Clark, J. C., Wren, C. G. et al. (1992). In vitro activities of penciclovir and acyclovir against herpes simplex virus types 1 and 2. Antimicrobial Agents and Chemotherapy 36, 2037-8.
28. Weller, S., Blum, M. R., Doucette, M., Burnette, T., Cederberg, D. M., de Miranda, P. et al. (1993). Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers. Clinical Pharmacology and Therapeutics 54, 595-605.